Table 3.
Vaccine coverage by age distributions for the 2016 birth cohort across 152 low-income and middle-income countries for BCG, the first dose of diphtheria–tetanus–pertussis vaccine (DTP1), and the first dose of measles-containing vaccine (MCV1)
| WHO recommended age of first dose | Age by which 50% coverage of the 2016 birth cohort is achieved | Estimated coverage of the 2016 birth cohort at 1 year of age | Estimated coverage of the 2016 birth cohort at 3 years of age | Comments | |
|---|---|---|---|---|---|
| BCG | At birth or as soon as possible after birth | Between 2 and 3 weeks of age | 90% | 92% | An estimated 37% of the 2016 birth cohort received BCG in the first week of life |
| DTP1 | 6 weeks | Between 9 and 10 weeks of age | 89% | 94% | An estimated 7·7% of the 2016 birth cohort received DTP1 before 6 weeks of age |
| MCV1 | 9 or 12 months | Between 43 and 44 weeks of age | 67% | 93% | An estimated 9·6% of the 2016 birth cohort received MCV1 before 9 months of age |